Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term nucleos(t)ide analogue and alpha-interferon combination therapy for chronic hepatitis B
ChiCTR-TNRC-10001067Phase 4Recruiting
- Sponsor
- Beijing YouAn Hospital
- Start
- Jan 2001
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of interferon alfa-n1 in Chronic Hepatitis B (CHB) (3 arms), sponsored by Beijing YouAn Hospital. Primary endpoints: HBV DNA, HBeAg and 1 more. Started Jan 2001; status: recruiting.
02
Drugs
interferon alfa-n1
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-TNRC-10001067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNRC-10001067.